Formulation and characterization of ascorbic acid-based zinc oxide nanoparticles for assessing antidiabetic and neuroprotective effects in STZ-induced diabetic rats
* < 0.001), decreased hippocampal acetylcholinesterase (AChE) activity and preserved neuronal architecture. Overall, the ZnO-AA nanoformulation represents a multifunctional nanomedicine technique that improves the therapeutic efficacy of AA and has considerable promise for the treatment of diabetes and its associated neurodegenerative consequences.
Authors
- Syed Sagheer Ahmed (ORCID: https://orcid.org/0000-0001-9817-9747)
- Yahya Alhamhoom (ORCID: https://orcid.org/0000-0002-8368-9047)
- Ismail Pasha (ORCID: https://orcid.org/0009-0005-2579-4032)
- Mohammed Muqtader Ahmed (ORCID: https://orcid.org/0000-0001-6911-0652)
- Mohamed Rahamathulla (ORCID: https://orcid.org/0000-0001-8826-3718)
- Mohammad Ali (ORCID: https://orcid.org/0000-0002-9404-9301)
- Sindu M. B (ORCID: https://orcid.org/0009-0004-2196-6442)
- Ali Alamri
- Bharathi D. R
Institutions
- Prince Sattam Bin Abdulaziz University (SA)
- Yichun University (CN)
- King Khalid University (SA)
Publication Details
- Journal
- Artificial Cells Nanomedicine and Biotechnology
- Published
- 2026-04-28
- DOI
- https://doi.org/10.1080/21691401.2026.2662205
- Primary Topic
- Natural Antidiabetic Agents Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deanship of Scientific Research, King Khalid University